🔴 Cue Biopharma is trading 10% down today as U.S.-Iran stalemate lifts oil and Treasury yields

Cue Biopharma is trading at $28.25, down 10.05%, alongside broad market weakness tied to inflation and rate concerns.

• No clear company-specific announcement was identified for September 28; positive CUE-221 Phase 2 results were announced September 20, before the recent pullback.
• Reuters reported Brent crude rose 4% to $108.5 a barrel and 10-year yields climbed 4 basis points to 5.22%, as the U.S.-Iran stalemate stoked inflation and rate concerns.
• Major U.S. indices were down more than 0.5%.